pyridostigmine bromide

Generic: pyridostigmine bromide

Labeler: amneal pharmaceuticals ny llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name pyridostigmine bromide
Generic Name pyridostigmine bromide
Labeler amneal pharmaceuticals ny llc
Dosage Form SOLUTION
Routes
ORAL
Active Ingredients

pyridostigmine bromide 60 mg/5mL

Manufacturer
Amneal Pharmaceuticals NY LLC

Identifiers & Regulatory

Product NDC 69238-1731
Product ID 69238-1731_c11900df-97bb-47f5-8a29-05fe1586d556
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA212702
Listing Expiration 2026-12-31
Marketing Start 2020-01-17

Pharmacologic Class

Classes
cholinesterase inhibitor [epc] cholinesterase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 692381731
Hyphenated Format 69238-1731

Supplemental Identifiers

RxCUI
903843
UNII
KVI301NA53

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name pyridostigmine bromide (source: ndc)
Generic Name pyridostigmine bromide (source: ndc)
Application Number ANDA212702 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 60 mg/5mL
source: ndc
Packaging
  • 473 mL in 1 BOTTLE (69238-1731-2)
source: ndc

Packages (1)

Ingredients (1)

pyridostigmine bromide (60 mg/5mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c11900df-97bb-47f5-8a29-05fe1586d556", "openfda": {"unii": ["KVI301NA53"], "rxcui": ["903843"], "spl_set_id": ["9c3a5abf-e217-4292-a305-5afd12b99e95"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE (69238-1731-2)", "package_ndc": "69238-1731-2", "marketing_start_date": "20200117"}], "brand_name": "Pyridostigmine Bromide", "product_id": "69238-1731_c11900df-97bb-47f5-8a29-05fe1586d556", "dosage_form": "SOLUTION", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "69238-1731", "generic_name": "Pyridostigmine Bromide", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pyridostigmine Bromide", "active_ingredients": [{"name": "PYRIDOSTIGMINE BROMIDE", "strength": "60 mg/5mL"}], "application_number": "ANDA212702", "marketing_category": "ANDA", "marketing_start_date": "20200117", "listing_expiration_date": "20261231"}